Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deficiency of miR-155 in leukemic B-cells results in cell cycle arrest and deregulation of MIR155HG/TP53INP1/CDKN1A/CCND1 network.
Golovina E, Kokavec J, Kazantsev D, Yurikova O, Bajecny M, Savvulidi FG, Simersky R, Lenobel R, Tost J, Herynek V, Sefc L, Sebela M, Klener P, Zemanova Z, Stopka T, Vargova KS. Golovina E, et al. Among authors: klener p. Arch Med Res. 2024 Nov 25;56(3):103124. doi: 10.1016/j.arcmed.2024.103124. Online ahead of print. Arch Med Res. 2024. PMID: 39591901 Free article.
Surgical results in patients with CNS lymphoma. Comparison of predictive value of intraoperative MRI and intraoperative histological examination for diagnostic biopsy yield.
Majovsky M, Moravec T, Komarc M, Soukup J, Sedlak V, Balasubramaniam N, Brixi J, Klener P, Klanova M, Netuka D. Majovsky M, et al. Among authors: klener p. Brain Spine. 2024 Oct 18;4:103926. doi: 10.1016/j.bas.2024.103926. eCollection 2024. Brain Spine. 2024. PMID: 39524302 Free PMC article.
Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma.
Willis BS, Mongeon K, Dry H, Neveras IL, Bryan N, Pandya M, Roderick-Richardson J, Xu W, Yang L, Rosen A, Reimer C, Tuskova L, Klener P, Mettetal JT, Lenz G, Barry ST. Willis BS, et al. Among authors: klener p. Leukemia. 2024 Dec;38(12):2663-2674. doi: 10.1038/s41375-024-02401-9. Epub 2024 Sep 16. Leukemia. 2024. PMID: 39284898 Free PMC article.
Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies.
Bettazova N, Senavova J, Kupcova K, Sovilj D, Rajmonova A, Andera L, Svobodova K, Berkova A, Zemanova Z, Daumova L, Herman V, Dolníkova A, Davis RE, Trneny M, Klener P, Havranek O. Bettazova N, et al. Among authors: klener p. Blood Adv. 2024 Oct 22;8(20):5279-5289. doi: 10.1182/bloodadvances.2024013205. Blood Adv. 2024. PMID: 39158100 Free PMC article.
301 results